Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Recce Pharmaceuticals Ltd. ( (AU:RCE) ) just unveiled an update.
Recce Pharmaceuticals Ltd presented at their Annual General Meeting in 2025, highlighting their strategic intentions and future plans. The presentation emphasized the company’s commitment to innovation in the pharmaceutical sector, particularly in combating antibiotic resistance. While the document outlines potential future strategies, it also acknowledges the inherent risks and uncertainties that could impact the company’s performance and operations.
The most recent analyst rating on (AU:RCE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Recce Pharmaceuticals Ltd. stock, see the AU:RCE Stock Forecast page.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd is a company in the pharmaceutical industry, focusing on the development of new classes of synthetic anti-infectives. The company is dedicated to addressing the growing issue of antibiotic resistance, with a market focus on providing innovative solutions for bacterial infections.
Average Trading Volume: 131,668
Technical Sentiment Signal: Hold
Current Market Cap: A$115.7M
Find detailed analytics on RCE stock on TipRanks’ Stock Analysis page.